What Is 3-Hydroxy-3-methylglutaric acid

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-Hydroxy-3-methylglutaric acid (HMG) is an organic acid involved in ketone body synthesis and leucine metabolism. It accumulates in the rare genetic disorder 3-hydroxy-3-methylglutaric aciduria, first described in 1976.

Key Facts

3-Hydroxy-3-methylglutaric acid is abbreviated as HMG in metabolic pathways
It plays a key role in ketogenesis and the catabolism of the amino acid leucine
Elevated levels are linked to 3-hydroxy-3-methylglutaric aciduria, a rare autosomal recessive disorder
The disorder was first clinically described in 1976 by Naito et al.
HMG accumulates due to a deficiency in the enzyme 3-hydroxy-3-methylglutaryl-CoA lyase

Overview

3-Hydroxy-3-methylglutaric acid (HMG) is an intermediate metabolite in the breakdown of the amino acid leucine and in the production of ketone bodies in the liver. It is formed during the metabolism of fats and proteins when energy demand is high, such as during fasting or prolonged exercise.

This compound is not typically found in high concentrations in healthy individuals, but its accumulation signals a metabolic disruption. Disorders involving HMG are rare but can be life-threatening if not diagnosed early. Understanding its role helps in diagnosing and managing inborn errors of metabolism.

Chemical formula: C₆H₁₀O₅, HMG is a dicarboxylic acid derived from HMG-CoA via hydrolysis.
Metabolic pathway: It is produced during the final step of leucine catabolism and ketogenesis in mitochondria.
Enzyme involved: 3-hydroxy-3-methylglutaryl-CoA lyase converts HMG-CoA into acetoacetate and acetyl-CoA.
Accumulation cause: Deficiency in HMG-CoA lyase leads to toxic buildup of HMG in blood and urine.
Clinical detection: Elevated HMG levels are detectable via tandem mass spectrometry in newborn screening panels.

How It Works

3-Hydroxy-3-methylglutaric acid functions as a transient intermediate in energy-producing metabolic pathways. Its formation and clearance are tightly regulated, and disruptions can lead to metabolic acidosis and neurological complications.

Ketogenesis: In the liver, HMG is a precursor to acetoacetate, one of the primary ketone bodies used during fasting.
Leucine catabolism: HMG is formed when leucine is broken down, requiring multiple enzymatic steps in mitochondria.
Enzyme deficiency: A mutation in the HMGCL gene causes 3-hydroxy-3-methylglutaric aciduria, affecting enzyme activity.
Metabolic block: Without functional HMG-CoA lyase, HMG accumulates and disrupts cellular pH and energy balance.
Energy deficit: The body cannot efficiently produce ketones, leading to hypoglycemia during metabolic stress.
Toxicity mechanism: Accumulated HMG inhibits other mitochondrial enzymes, impairing ATP production and urea cycle function.

Comparison at a Glance

Below is a comparison of 3-hydroxy-3-methylglutaric acid and related metabolites in human metabolism:

Metabolite	Pathway	Normal Function	Associated Disorder	Onset Age
3-Hydroxy-3-methylglutaric acid	Ketogenesis, Leucine catabolism	Intermediate in ketone and energy production	3-Hydroxy-3-methylglutaric aciduria	Infancy (0–2 years)
Acetoacetate	Ketogenesis	Main ketone body used for energy	Ketoacidosis (secondary)	Any (metabolic stress)
3-Methylglutaconic acid	Leucine catabolism	Intermediate metabolite	3-Methylglutaconic aciduria	Variable (neonatal to adult)
Malonyl-CoA	Fatty acid synthesis	Regulates fatty acid oxidation	Malonic aciduria	Infancy
Glutaric acid	Lysine metabolism	Byproduct of amino acid breakdown	Glutaric acidemia type I	6–18 months

This table highlights how different organic acidurias stem from disruptions in specific metabolic pathways. While all involve toxic metabolite accumulation, each has distinct biochemical markers and clinical presentations. 3-Hydroxy-3-methylglutaric aciduria is particularly notable for its acute presentation during catabolic states like illness or fasting, requiring prompt intervention.

Why It Matters

Understanding 3-hydroxy-3-methylglutaric acid is crucial for diagnosing and managing rare metabolic disorders, especially in pediatric populations. Early detection through newborn screening can prevent severe complications.

Diagnostic marker: Elevated HMG in plasma or urine is a key indicator of HMG-CoA lyase deficiency.
Newborn screening: Tandem mass spectrometry detects abnormal acylcarnitine profiles, including C6-OH species.
Clinical symptoms: Include vomiting, lethargy, hypoglycemia, and metabolic acidosis in infants.
Emergency management: Requires rapid glucose infusion and avoidance of protein during acute episodes.
Long-term care: Patients need a low-leucine diet and avoidance of prolonged fasting.
Genetic counseling: Families with affected children have a 25% recurrence risk due to autosomal recessive inheritance.

With advances in metabolic screening and genetic testing, outcomes for patients with 3-hydroxy-3-methylglutaric aciduria have improved significantly. However, awareness among clinicians remains essential to ensure timely diagnosis and treatment.